Graft-Versus-Host Reaction in the Skin: Why Is It Important for the Dermatologist

  • J. H. Saurat
Conference paper


In this paper, five points are summarized:
  1. 1

    What is a graft-versus-host disease (reaction).

  2. 2

    When and why does it occur.

  3. 3

    What is the spectrum of its cutaneous manifestations.

  4. 4

    What is (are) the mechanism(s) of the skin injury.

  5. 5

    How does GVHD pertain to clinical dermatology.



Chronic GVHD Lichen Planus Acceptor Molecule Clinical Dermatology Bone Marrow Graft 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Saurat JH (1984) Graft versus host reaction. In: MacKie RM (ed) Current perspectives in immunodermatology. Churchill Livingstone, Edinburgh, pp 236–252.Google Scholar
  2. 2.
    Sale GE (1984) Human graft-versus-host disease. Surv Synth Path Res 3:235–253.Google Scholar
  3. 3.
    Santos GW, Hess AD, Vogelsang GB (1985) Graft-versus host reactions and disease. Immunol Rev 88:169–192.PubMedCrossRefGoogle Scholar
  4. 4.
    Goldstein P (1987) Cytolytic T-cell melodrama. Nature 327:12.CrossRefGoogle Scholar
  5. 5.
    Elliott CJ, Sloane JP, Sanderson KV, Vincent M, Shepherd V, Powles R (1987) The histological diagnosis of cutaneous graft versus host disease: relationship of skin changes to marrow purging and other clinical variables. Histopathology 11:145–155.PubMedCrossRefGoogle Scholar
  6. 6.
    Graham-Brown RAC, Jones JAG, Shaw PV, Barnett DB (1987) A graft-versus-host disease-like syndrome. Br J Dermatol 116:249–252.PubMedCrossRefGoogle Scholar
  7. 7.
    Holmes RC, Cooper CB, Black MM et al. (1983) Syndrome resembling graft-versus-host disease in a patient with disseminated carcinoma. J R Soc Med 76:703–705.PubMedGoogle Scholar
  8. 8.
    Harper JI (1985) Case presented to meeting of Dermatology Section of Royal Society of Medicine. December.Google Scholar
  9. 9.
    Viraben R (1987) Communicat. à la Soc. Française de Dermatologie, Paris.Google Scholar
  10. 10.
    Beutler B, Cerami A (1987) Cachectin: more than a tumor necrosis factor. N Engl J Med 316:379–385.PubMedCrossRefGoogle Scholar
  11. 11.
    Atkinson K, Weiler P, Ryman W, Biggs J (1986) PUVA therapy for drug-resistant graft-versus-host disease. Bone Marrow Transpl 1:227–236.Google Scholar
  12. 12.
    Hymes SR, Morison WL, Farmer ER, Walters LL, Tutschka PJ, Santos GW (1985) Methoxsalen and ultraviolet A radiation in treatment of chronic cutaneous graft-versus-host reaction. J Am Acad Dermatol 12:30–37.PubMedCrossRefGoogle Scholar
  13. 13.
    Vogelsang GB, Hess AD, Gordon G, Santos GW (1986) Treatment and prevention of acute graft-versus-host disease with Thalidomide in a rat model. Transplantation 41:644–647.PubMedCrossRefGoogle Scholar
  14. 14.
    Knobler HY, Sagher U, Peled IJ, Wexler MR et al. (1985) Tolerance to donor-type skin in the recipient of a bone marrow allograft. Treatment of skin ulcers in chronic graft-versus-host disease with skin grafts from the bone marrow donor. Transplantation 40:223–225.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • J. H. Saurat
    • 1
  1. 1.Department of DermatologyUniversity of GenevaGenevaSwitzerland

Personalised recommendations